Atlas Trials

Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer

Clinical trial NCT04138342 · UNKNOWN

Trial details

NCT number
NCT04138342
Sponsor
Al-Azhar University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Breast CancerSkin CancerSkin Diseases
Start date
2019-09-15
Primary completion
2021-06-14
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.